See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597264_2021_Blueprint_Medicines_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001597264, Blueprint Medicines Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 927,759,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 34,129,000 |
| 3 | remainder_Assets | 756,505,000 |
| 4 | LiabilitiesCurrent | 130,802,000 |
| 5 | LiabilitiesNoncurrent | 117,503,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 425,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 464,398,883 |
| 9 | ResearchAndDevelopmentExpense | 317,020,238 |
| 10 | remainder_Expenses | 1,058,000 |
| 11 | remainder_Revenues | 4,409,514,821 |
| 12 | remainder_NetIncome | 2,783,579 |
| 13 | remainder_ComprehensiveNetIncome | -2,674,300 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,718,393,000 |
| 1 | Liabilities | 248,305,000 |
| 2 | Expenses | 782,902,121 |
| 3 | Revenues | 4,409,514,821 |
| 4 | StockholdersEquity | 1,470,088,000 |
| 5 | NetIncome | 3,629,396,279 |
| 6 | ComprehensiveNetIncome | 3,628,059,129 |
| 7 | BaseVar | 3,582,286,410 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 6.95 |
| 9 | EconomicCapitalRatio | 6.98 |